title: Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Woodman
authors.forename: Trevor A
authors.initials: TA
authors.lastname: Mori
authors.forename: Valerie
authors.initials: V
authors.lastname: Burke
authors.forename: Ian B
authors.initials: IB
authors.lastname: Puddey
authors.forename: Gerald F
authors.initials: GF
authors.lastname: Watts
authors.forename: James D
authors.initials: JD
authors.lastname: Best
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Beilin
mesh_terms: D000328:Adult; D000368:Aged; D008078:Cholesterol, LDL / Q000097:blood* / Q000737:chemistry; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy*; D004281:Docosahexaenoic Acids / Q000627:therapeutic use*; D015118:Eicosapentaenoic Acid; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy; D006977:Hypertension, Renal / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010316:Particle Size
chemical_list: D008078:Cholesterol, LDL; D005231:Fatty Acids, Unsaturated; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid